OUTCOME AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION WITH REDUCED-INTENSITY CONDITIONING IN PATIENTS WITH MULTIPLE MYELOMA

被引：0
|
作者：
Bourcier, J. [1 ]
Malard, F. [1 ]
Chevallier, P. [1 ]
Guillaume, T. [1 ]
Delaunay, J. [1 ]
Peterlin, P. [1 ]
Mohty, M. [2 ]
Moreau, P. [1 ]
机构：
[1] CHU Nantes, F-44035 Nantes 01, France
[2] CHU, AP HP, Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P516
引用
收藏
页码：S346 / S347
页数：2
相关论文
共 50 条
  • [1] Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma
    El-Cheikh, Jean
    Crocchiolo, Roberto
    Furst, Sabine
    Stoppa, Anne-Marie
    Ladaique, Patrick
    Faucher, Catherine
    Calmels, Boris
    Lemarie, Claude
    De Colella, Jean-Marc Schiano
    Granata, Angela
    Coso, Diane
    Bouabdallah, Reda
    Chabannon, Christian
    Blaise, Didier
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : 370 - 374
  • [2] Reduced-intensity conditioning allogeneic stem cell transplantation for multiple myeloma
    Garcia, A
    Sureda, A
    Martino, R
    Valcarcel, D
    Brunet, S
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S200 - S200
  • [3] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Taku Kikuchi
    Takehiko Mori
    Yuya Koda
    Sumiko Kohashi
    Jun Kato
    Takaaki Toyama
    Tomonori Nakazato
    Yoshinobu Aisa
    Takayuki Shimizu
    Shinichiro Okamoto
    [J]. International Journal of Hematology, 2015, 102 : 670 - 677
  • [4] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Kikuchi, Taku
    Mori, Takehiko
    Koda, Yuya
    Kohashi, Sumiko
    Kato, Jun
    Toyama, Takaaki
    Nakazato, Tomonori
    Aisa, Yoshinobu
    Shimizu, Takayuki
    Okamoto, Shinichiro
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (06) : 670 - 677
  • [5] Bortezomib for relapse after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for multiple myeloma
    Michallet, M
    Duscatelle, S
    Rafii, H
    Troncy, J
    Thiebaut, A
    Thomas, X
    Tavernier, E
    Le, QH
    Raus, N
    Praire, A
    Nicolini, F
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S389 - S389
  • [6] A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation
    Le Blanc, K
    Remberger, M
    Uzunel, M
    Mansson, J
    Barkholt, L
    Ringdén, O
    [J]. TRANSPLANTATION, 2004, 78 (07) : 1014 - 1020
  • [7] Reduced-intensity conditioning with treosulfan and fludarabine prior to allogeneic stem cell transplantation in multiple myeloma patients
    Schmidt-Hieber, M
    Casper, J
    Trenschel, R
    Andreesen, R
    Einsele, H
    Kanz, L
    Fauser, A
    Uharek, L
    Thiel, E
    Blau, I
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S195 - S196
  • [8] Reduced intensity conditioning for allogeneic stem cell transplantation in patients with multiple myeloma
    Vaz, CP
    Campilho, F
    Campos, A
    Guerra, M
    Mendez, JC
    Soares, M
    Martinho, A
    Barbosa, IL
    Roncon, S
    Carvalhais, A
    Pimentel, P
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
  • [9] Salvage therapy with bortezomib for advanced multiple myeloma after reduced-intensity conditioning allogeneic stem cell transplantation
    El Cheikh, J.
    Stoppa, A. M.
    Aurran, T.
    Rey, J.
    Bouabdallah, R.
    Vey, N.
    Coso, D.
    Ivanov, V.
    Charbonnier, A.
    Faucher, C.
    Schiano De Collela, J. M.
    Gastaut, J. A.
    Blaise, D.
    Mohty, M.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S154 - S154
  • [10] Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced
    Shimoni, A.
    Shem-Tov, N.
    Chetrit, A.
    Volchek, Y.
    Tallis, E.
    Avigdor, A.
    Sadetzki, S.
    Yerushalmi, R.
    Nagler, A.
    [J]. LEUKEMIA, 2013, 27 (04) : 829 - 835
12345